[{"id":"873c0c2e-513f-43f3-bf7d-2bd89d10f56d","acronym":"","url":"https://clinicaltrials.gov/study/NCT04540796","created_at":"2021-08-31T00:53:14.343Z","updated_at":"2025-02-25T17:00:38.256Z","phase":"Phase 1","brief_title":"A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)","source_id_and_acronym":"NCT04540796","lead_sponsor":"Janssen Research \u0026 Development, LLC","biomarkers":" BCL2","pipe":"","alterations":" ","tags":["BCL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e rezetamig (JNJ-8780)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 147","initiation":"Initiation: 11/20/2020","start_date":" 11/20/2020","primary_txt":" Primary completion: 04/04/2025","primary_completion_date":" 04/04/2025","study_txt":" Completion: 05/31/2025","study_completion_date":" 05/31/2025","last_update_posted":"2025-02-03"}]